| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |